Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.
Small airway inflammation and smooth muscle dysfunction (Figure 4) are not the only targets of treatment in asthma and COPD. Mucociliary dysfunction, chronic infections with advancing ...
Tezspire is currently approved for severe asthma in the US ... were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). Chronic rhinosinusitis with nasal ...